Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: Ann Neurol. 2020 Nov 20;89(2):293–303. doi: 10.1002/ana.25952

Table 2:

Patient Characteristics by Alpha-Synucleinopathy

Control (N = 444) PD (N = 308) DLB (N = 81) PDD (N = 55) Total (N = 888)
Race
  Asian 13 (2.9%) 9 (2.2%) 3 (3.7%) 0 (0%) 25 (2.8%)
  Black or African American 1 (0.2%) 2 (0.6%) 1 (1.2%) 0 (0%) 4 (0.5%)
  Other/Mixed 6 (1.4%) 1 (0.3%) 0 (0%) 1 (1.8%) 8 (0.9%)
  White 424 (95.5%) 296 (96.1%) 77 (95.1%) 54 (98.2%) 851 (95.8%)
Sex
  Male 264 (59.5%) 182 (59.1%) 56 (69.1%) 26 (47.3%) 528 (59.5%)
Death
  Deceased 255 (57.4%) 232 (75.3%) 81 (100%) 55 (100%) 623 (70.2%)
Age at Parkinsonism Onset
  Overall 76 (67, 81) 73 (65, 80) 77 (72, 80) 81 (76, 86) 75 (67, 81)
  Female 76 (67, 83) 74 (66, 81) 78 (73, 81) 81 (76, 87) 76 (68, 83)
  Male 74 (66, 81) 73 (65, 80) 76 (72, 79) 81 (76, 84) 75 (67, 80)
Age at Death
  Overall 88 (83, 92) 86 (79, 90) 83 (79, 87) 84 (79, 90) 84 (79, 89)
  Female 90 (85, 94) 87 (81, 92) 84 (80, 87) 88 (80, 90) 86 (80, 91)
  Male 87 (83, 91) 84 (77, 89) 83 (79, 86) 83 (80, 88) 83 (78, 88)
RBD Diagnosis
  Yes 2 (0.5%) 55 (17.9%) 29 (35.8%) 2 (3.6%) 88 (9.9%)

Note: Age at Parkinsonism Onset for controls refers to age at control index date